Skip to search formSkip to main contentSkip to account menu

Imnovid

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

pomalidomide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA
2016
2016
Pharmacoeconomic evaluation of pomalidomide (imnovid) use in treatment of patients with relapsed or refractory multiple myeloma who have received at least two lines of therapy comprising lenalidomide…
2016
2016
Pomalidomida (▼ Imnovid): riesgo de reactivación de la hepatitis B asociado a su uso
Review
2014
Review
2014
POMALIDOMID – nowy immunomodulujący lek w terapii szpiczaka plazmocytowego
2013
2013
Produkt Imnovid
Imnovid® ist ein neuer Wirkstoff aus der Klasse der IMiDs® (Immunmodulatoren). Mit einer Standarddosierung von 4 mg (orale Gabe… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)